Log in to save to my catalogue

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_50253ef611194e4595e03d647adf9305

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

About this item

Full title

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-08, Vol.13 (1), p.13489-13489, Article 13489

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Prostate cancer (PCa) development and progression relies on the programming of glucose and lipid metabolism, and this involves alterations in androgen receptor expression and signalling. Defining the molecular mechanism that underpins this metabolic programming will have direct significance for patients with PCa who have a poor prognosis. Here we s...

Alternative Titles

Full title

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_50253ef611194e4595e03d647adf9305

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_50253ef611194e4595e03d647adf9305

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-40347-7

How to access this item